Literature DB >> 15940428

New method for DNA microarrays development: applied to human platelet antigens polymorphisms.

J-C Brès1, Y Mérieux, V Dugas, J Broutin, E Vnuk, M Jaber, D Rigal, J-R Martin, E Souteyrand, M Cabrera, J-P Cloarec.   

Abstract

DNA microarrays are a powerful experimental tool for the detection of specific genomic sequences and are invaluable to a broad array of applications: clinical diagnosis, personalized medicine, drug research and development, gene therapy, food control technologies, and environmental sciences. Alloimmunization to human platelet antigens (HPAs) is commonly responsible for neonatal alloimmune thrombocytopenia, post-transfusional purpura and platelet transfusion refractoriness. Using DNA microarrays, we developed a diagnosis to type the biallelic HPA-1 platelet group. The region for the human genomic DNA sequence that contains the polymorphism responsible for HPA-1 alleles was amplified by polymerase chain reaction (PCR). The expected DNA fragments were hybridized on DNA microarrays, and the data were analyzed using specially developed software. Our initial results show that the two HPA-1 antigens polymorphisms containing a single base difference were detected using DNA microarrays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940428     DOI: 10.1007/s10544-005-1593-0

Source DB:  PubMed          Journal:  Biomed Microdevices        ISSN: 1387-2176            Impact factor:   2.838


  2 in total

Review 1.  Detection of blood-transmissible agents: can screening be miniaturized?

Authors:  Chantal Fournier-Wirth; Nicole Jaffrezic-Renault; Joliette Coste
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

2.  Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions.

Authors:  Juliana Vieira Dos Santos Bianchi; Maria Regina Andrade de Azevedo; Eduardo Jens; Youko Nukui; Dalton Alencar Ficher Chamone
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.